Related Experiment Video

Updated: Jul 9, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

New T-Cell Therapies for Brain Metastasis, CD133 in the Driver's Seat

Anthony R Sloan1,2, Mihika Thapliyal1,3, Justin D Lathia1,2,3,4

  • 1Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|December 1, 2023
PubMed

Insights

Researchers developed a new CAR-T cell therapy targeting the CD133 antigen on cancer stem cells. This approach aims to improve treatment for brain metastasis by targeting a key cancer cell surface marker.

Area of Science:

  • Oncology
  • Immunotherapy
  • Cancer Stem Cell Biology

Background:

  • Chimeric antigen receptor (CAR)-T cell therapy shows promise for advanced cancers.
  • Effective CAR-T therapy relies on identifying specific cancer cell surface targets.
  • Brain metastasis presents unique therapeutic challenges.

Purpose of the Study:

  • To develop a novel CAR-T cell therapy for brain metastasis.
  • To utilize the cancer stem cell surface antigen CD133 as a therapeutic target.

Main Methods:

  • Leveraging the CD133 antigen for CAR-T cell therapy development.
  • Application of CAR-T cell immunotherapy in the context of brain metastasis.

Main Results:

  • Successful development of a CAR-T therapy targeting CD133.
  • Potential for improved efficacy in treating brain metastasis.

Conclusions:

  • Targeting CD133 with CAR-T cells is a viable strategy for brain metastasis.
  • This approach offers a new avenue for advanced cancer treatment.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.6K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K